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Treatment of oximes with hypervalent iodine leads to substituted
isoxazoles via rapid formation of nitrile oxides. Reaction with
terminal alkynes led to a series of 3,5-disubstituted isoxazoles
with complete regioselectivity and high yield, in a procedure mild
enough to prepare a range of nucleoside and peptide conjugates.
Exceptionally high reaction rates were found for the formation
of 3,4,5-trisubstituted isoxazoles from a cyclic alkyne.
Isoxazoles form a major class of nitrogen heterocycles that are
molecular components in a variety of natural products (e.g.
ibotenic acid, muscimol, isoxazole-4-carboxylic acid) and drugs
(e.g. valdecoxib, leﬂunomide, cloxacillin).1 A variety of synthetic
methods has been developed for the preparation of isoxazoles,2 of
which the cycloaddition of nitrile oxides and alkynes is probably
the most direct.3 However, thermal nitrile oxide–alkyne cyclo-
additions typically give low yields, side-reactions and poor regio-
selectivity.4 Copper(I) and ruthenium(II)-induced preparation of
3,5- or 3,4-disubstituted isoxazoles has been reported,5 but
for many applications the use of (toxic) transition metals is
undesirable if not prohibited. Therefore, there exists a clear need
for metal-free, regioselective synthesis of isoxazoles.
Recently, it was reported that 3,5-disubstituted isoxazolines
can be prepared by cycloaddition to oleﬁns and nitrile oxides,
generated in situ from oximes with (diacetoxyiodo)benzene
(DIB) with catalytic TFA (Scheme 1, top).6 A single example
of isoxazole preparation was also given, but the methodology
was not further elaborated, presumably as a consequence of
the low yield (50%) of the reaction. Herein, we report a
methodology for a completely regioselective and high yielding
procedure for the preparation of 3,5-disubstituted and
3,4,5-trisubstituted isoxazoles from terminal or cyclic alkynes,
respectively. Key to the strategy is near instantaneous
generation of nitrile oxides from oximes by use of phenyl-
iodine bis(triﬂuoroacetate) as an oxidising agent. The versatility
of the procedure and applicability as a novel tool for
bioconjugation is demonstrated by preparation of a range of
nucleoside and peptide-containing isoxazoles.7
Due to its low toxicity, ready availability and easy handling,
phenyliodine bis(triﬂuoroacetate) (PIFA) is a useful reagent
for oxidative dearomatisation, dehydrodimerisation and
selective cyanation.8 To date, however, PIFA has not been
applied for the generation of nitrile oxide from oximes. We
therefore investigated the reaction of phenylacetylene and
benzaldoxime under the action of PIFA (ESIw and Table 1).
A slow conversion was observed in MeCN, i-PrOH or in 1,4-
dioxane/H2O (5 : 1) mixtures but in MeOH/H2O (5 : 1), a
highly eﬃcient reaction took place.9 A small excess (1.5 equiv.)
of oxime is required for the reaction as a result of the fact that
the in situ formed nitrile oxide slowly homodimerizes to
furoxan or 1,4-dioxo-2,5-diazine.4,10 Therefore, the eﬀect of
portion-wise addition of PIFA and reaction concentration was
investigated (Table 1). When benzaldoxime (1.5 equiv.) and
PIFA (1.5 equiv.) were combined with phenylacetylene
(0.01 M), the expected 3,5-disubstituted isoxazole was
obtained in 65% yield. Addition of PIFA in two portions
(total 1.5 equiv.) improved the yield to 70%. Further increasing
the reaction concentration (with respect to alkyne) to 0.1 M
and addition of PIFA in three portions over 2 h intervals
Scheme 1 Cycloaddition of nitrile oxides to alkenes or acetylenes via
hypervalent iodine-induced generation of nitrile oxide from oxime.
Table 1 Cycloaddition of phenylacetylene and benzonitrile-N-oxide
Entry Conc.a/M
Oxime
(equiv.)
PIFA addition
(1.5 equiv.) Time/h Yield (%)
1 0.01 1.5 1 portion 24 65
2 0.01 1.5 2 portions/4 h 24 70
3 0.1 1.5 3 portions/2 h 7 90
a Concentration of phenylacetylene.
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(1.5 equiv. in total), gave the desired isoxazole in 90% yield
after 7 h. The beneﬁcial role of PIFA is explained by the near
instantaneous formation (1 min) of nitrile oxide from
p-methylbenzaldoxime (Fig. S1, ESIw), while oxidation with
DIB is sluggish and incomplete after 60 min (Fig. S2, ESIw).
Having established optimal conditions for in situ generation
of nitrile oxide, and cycloaddition to acetylene, the scope of
isoxazole formation was evaluated for a range of substrates
(Table 2). A variety of aromatic or aliphatic oximes or
alkynes, with electron-deﬁcient or electron-rich groups, was
converted to 3,5-disubstituted isoxazoles in good to excellent
yields. Aliphatic alkynes were less reactive than aromatic
alkynes giving 55–66% product based on the oxime used.
However, use of four-fold excess of oxime raised the yield to
94% (entry 16). No competitive cycloaddition of nitrile oxides
to oleﬁns was observed in case of trans-cinnamaldoxime
(entries 9–12). It must be noted that the yields obtained in
our procedure compare favorably to the copper-catalysed
synthesis of isoxazoles, especially in case of benzaldoxime
(entry 1) and 4-nitrobenzaldoxime (entry 17).5a,b
The scope of nitrile oxide–alkyne cycloaddition for bio-
conjugation was explored by application to a range of
nucleosides and a model peptide (Fig. 1). To our delight,
PIFA-induced (3 + 2) cycloaddition works well with unpro-
tected nucleosides and a 20-alkyl adenosine-derived11 oxime,
leading to adducts 21–24, thereby tolerating various functional
groups (ESIw, Fig. S3). Finally, we successfully prepared an
isoxazole from a peptide with an N-terminal acetylene. To this
end, freshly generated nitrile oxide from benzaloxime
(3 equiv.) in MeOH (210 mL) was added to the peptide
(100 mM in H2O), which was repeated six times over 12 h,
leading to clean formation of isoxazole (495% conversion),
as conﬁrmed by HPLC and HRMS (Fig. S4, ESIw).
Having demonstrated the viability of PIFA-induced cyclo-
addition of nitrile oxides and terminal alkynes, we next investi-
gated strain-promoted reactions with cyclic alkynes, known to
undergo rapid cycloadditions with azides12,13 and nitrones.14
We recently developed a straightforward route to a novel
cyclooctyne analogue, namely bicyclo[6.1.0]nonyne (BCN),
for metal-free cycloaddition reactions.15 In this context, the
cycloaddition of BCN with nitrile oxide could constitute
another versatile metal-free ligation strategy.16 Thus, a series
of aromatic, aliphatic and unsaturated oximes was combined
with BCN (Scheme 2) in 1 : 1 mixture of MeOH/H2O (0.1 M),
before oxime and PIFA (each 1.2 equiv.) were added. As
expected, the reaction was extremely fast and eﬃcient giving
3,4,5-trisubstituted isoxazoles (compounds 26–34, Scheme 2) in
excellent yields within 2–5 min in all cases. Based on NMR
experiments (ESIw), a reaction rate constant of 1.8 M1 s1 was
determined for benzonitrile-N-oxide, a value that compares
highly favourably with that of benzyl azide cycloaddition to
BCN under identical conditions (0.18 M1 s1).
In conclusion, we have demonstrated the use of
PhI(OCOCF3)2 for the rapid in situ conversion of aldoximes
into nitrile oxide and cycloaddition with alkynes. The procedure
is experimentally convenient, avoiding the isolation and handling
of potentially harmful and unstable hydroximoyl chlorides.
The resulting nitrile oxide traps terminal and cyclic alkynes
eﬃciently, in particular in the case of cyclic alkynes,17 to give
3,5-disubstituted and 3,4,5-trisubstituted isoxazoles in high yield.
Because no transition metal catalyst is needed and a wide variety
of functional groups are tolerated, we foresee high usefulness of
Table 2 Isoxazoles from terminal alkynes and nitrile oxides
Entry Product
Yield
(%) Entry Product
Yield
(%)
1 90 11 65
2 80 12 61a
3 81 13 71
4 49a 14 67a
5 76 15 72
6 90 16
66a
94c
7 60 17 73
8 10b 18 59a
9 82 19 87
10 72 20 80
a Based on oxime. b Volatile. c 4 equiv. oxime used.
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our PIFA-mediated synthesis of isoxazoles.18 Currently, we are
making progress on the application of our approach for labeling
of oligonucleotides7b–d and for nitrile oxide–acetylene cyclo-
addition to proteins, which may unveil unprecedented ways for
metal-free conjugation of proteins containing acetylenes.19
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